Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
APO-EPO (epoetin alfa biosimilar) / Apotex
2011-005057-31: Study of safety and efficacy of APO-EPO versus US licensed Procrit® in patients with anemia of chronic kidney disease stage 5D		3	155	Europe	n/a, APO-EPO, n/a, Procrit®, Procrit®	APOTEX Inc., APOTEX Inc.	Anemia and chronic kidney disease stage 5D (patients on stable hemodialysis)